Maynard Um
-
-
-
-
-
-
-
Prelude Therapeutics secures $60M from Incyte option deal
-
-
-
-
-
-
-
Prelude Therapeutics Incorporated (PRLD) Tops Q3 EPS by 4c
-
-
-
-
-
-
-
Prelude Therapeutics Inc. (PRLD) Announces Clinical Collaboration with Mer zk to Evaluate PRT3789 plus KEYTRUDA
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

